A holistic approach to the management of hyperkalaemia: Heart failure specialist nurse and the multidisciplinary team
Seminar
•
AstraZeneca
About the CPD course
This presentation has been developed for heart failure specialist nurses (HFSNs) in the UK; providing an overview of hyperkalaemia in patients with heart failure and the role of HFSNs in managing hyperkalaemia in secondary care. This presentation aims to provide HFSNs information about the impact of hyperkalaemia in patients with heart failure; and how to identify and manage these patients in secondary care. The presentation will also highlight the importance of HFSNs; including their role in optimising outcomes for patients with heart failure and hyperkalaemia and as part of a multidisciplinary team in the heart failure care network.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
